VJC 2018 - #50 Tocilizumab for the management of immune mediated adverse events secondary to PD- 1 blockade

No Description

JOPP First Published December 5, 2017 <a href="http://journals.sagepub.com/doi/pdf/10.1177/1078155217745144" target="_blank">Full Text (PDF) </a> You have 10 minutes to finish the survey. The quiz will begin once you click the next button. Do your best to answer each question correctly. Good luck! You will be able to retry if you do not pass. However, we recommend studying the article before trying again.

Return to the quiz maker homepage.

Sorry. You need to have Javascript enabled to view this content. It is designed for use with Internet Explorer 8+, Firefox 10+, Chrome 17+, Android 2.0+, iOS 4.0+